Autologous cell therapy with CD133+ bone marrow-derived stem cells for Asherman Syndrome: a phase 1/2 trial
Unlocking the Secrets of Asherman’s Syndrome: A New Era of Personalized Treatment Asherman’s Syndrome, a condition characterized by intrauterine adhesions (scar tissue) often following uterine surgery like D&C, has long presented a significant challenge for women seeking to build families. For decades, treatment focused primarily on hysteroscopic adhesiolysis – surgically cutting away the scar tissue. … Read more